Skip to main content
OpenTrials

Clinical trial condition

Advanced Solid Tumor

Explore clinical trials studying Advanced Solid Tumor. Study availability and eligibility vary by location and protocol.

524 public trials 244 recruiting studies
Refine in advanced search Browse all conditions

Advanced Solid Tumor trial results

Completed

Study of RP-3500, Camonsertib, in Advanced Solid Tumors

NCT04497116

Conditions
Advanced Solid Tumor
Locations
  • #1014, Northwestern University Chicago, Illinois, United States
  • #1006, Massachusetts General Hospital Boston, Massachusetts, United States
  • #1002, Dana Farber Cancer Institute Boston, Massachusetts, United States
  • #1004, Memorial Sloan Kettering Cancer Institute New York, United States
View all 13 locations
View Trial Details
Completed

PRT3789 Monotherapy and in Combo w/Docetaxel in Participants w/Advanced or Metastatic Solid Tumors w/SMARCA4 Mutation

NCT05639751

Conditions
Advanced Solid Tumor, Metastatic Solid Tumor, Neoplasm Metastasis, +6 more
Locations
  • University of California, Davis Comprehensive Cancer Center Sacramento, California, United States
  • UCLA Hematology/Oncology - Santa Monica Santa Monica, California, United States
  • Smilow Cancer Hospital Phase 1 Unit New Haven, Connecticut, United States
  • AdventHealth Medical Group Oncology Research at Celebration Celebration, Florida, United States
View all 32 locations
View Trial Details
Completed

A Study of HMBD-002, a Monoclonal Antibody Targeting VISTA, as Monotherapy and Combined With Pembrolizumab, in Patients With Advanced Solid Tumors

NCT05082610

Conditions
Advanced Solid Tumor, Breast Diseases, Breast Neoplasms, +23 more
Locations
  • The City of Hope National Medical Center Duarte, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Stanford Cancer Institute Palo Alto, California, United States
  • Smilow Cancer Hospital - Yale New Heaven Health New Haven, Connecticut, United States
View Trial Details
Completed

A Study of MGC018 in Combination With MGD019 in Participants With Advanced Solid Tumors

NCT05293496

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Solid Tumor, +53 more
Locations
  • University of California, Los Angeles Los Angeles, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Florida Cancer Specialists and Research Institute Sarasota, Florida, United States
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
View Trial Details
Completed

Safety and Preliminary Effectiveness of BGB-A445 in Combination With Tislelizumab in Participants With Advanced Solid Tumors

NCT04215978

Conditions
Advanced Solid Tumor, Bronchial Neoplasms, Carcinoma, +25 more
Locations
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • California Cancer Associates for Research & Excellence (cCARE) San Diego, California, United States
  • UPMC Hillman Cancer Center (Univ Of Pittsburgh) Pittsburgh, Pennsylvania, United States
  • Blacktown Cancer And Haematology Centre Blacktown, New South Wales, Australia
View all 30 locations
View Trial Details
Completed

Study of LM-108 as a Single Agent or in Combination With Anti-PD-1 Antibody in Subjects With Advanced Solid Tumours

NCT05199753

Conditions
Advanced Solid Tumor
Locations
  • Blacktown Hospital Sydney, New South Wales, Australia
  • Sunshine Coast University Private Hospital Birtinya, Queensland, Australia
  • ICON Cancer Centre South Brisbane, Queensland, Australia
  • Cabrini Health Limited Malvern, Victoria, Australia
View Trial Details
Completed

A Study to Evaluate AB308 in Combination With AB122 in Participants With Advanced Malignancies

NCT04772989

Conditions
Advanced Solid Tumor, Blood Protein Disorders, Bronchial Neoplasms, +62 more
Locations
  • UCLA Department of Medicine - Hematology/Oncology Los Angeles, California, United States
  • Mayo Clinic Jacksonville - PPDS Jacksonville, Florida, United States
  • Goshen Health System Goshen, Indiana, United States
  • Holden Comprehensive Cancer Center Iowa City, Iowa, United States
View all 22 locations
View Trial Details

Related conditions